Evaluation of Warfarin Use in Patients With Mental Health Conditions in a Rural Community Health Center System

Abell, Laura; Irwin, Adriane N.

doi:10.1177/8755122520960226

Cited by 1 publication

(4 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, despite widespread engagement by pharmacists in anticoagulation monitoring, only one article was identified that included warfarin management by pharmacists in FQHCs. 61 This contrasts with other efforts that have consolidated information on ambulatory care services, 75 suggesting a publication bias that impacts what roles for pharmacists are showcased in the literature. There is also some risk of selection bias in manuscript composition.…”

Section: Limitationsmentioning

confidence: 97%

“…As state regulations have changed allowing more widespread use of CPAs, this is reflected in the literature. Services have been developed for a wide range of disease states involving CPAs, including diabetes, 17 hypertension, 15 and behavioral health, 24,60 as well as drug therapy monitoring 28,61 …”

Section: Models and Tenets Of Pharmacist‐provided Carementioning

confidence: 99%

“…Interestingly, much of the literature identified was focused on practice innovations rather than long‐standing successful roles and services. For example, despite widespread engagement by pharmacists in anticoagulation monitoring, only one article was identified that included warfarin management by pharmacists in FQHCs 61 . This contrasts with other efforts that have consolidated information on ambulatory care services, 75 suggesting a publication bias that impacts what roles for pharmacists are showcased in the literature.…”

Section: Limitationsmentioning

confidence: 99%

“…Services have been developed for a wide range of disease states involving CPAs, including diabetes, 17 hypertension, 15 and behavioral health, 24,60 as well as drug therapy monitoring. 28,61 The increasing use and importance of CPAs was also evident as a strategy to further expand pharmacy services. In one example demonstrating that pharmacists could increase spirometry screening in highrisk patients created an opportunity to develop CPAs for tobacco dependence and COPD management.…”

Section: Collaborative Practice Agreementsmentioning

confidence: 99%

See 3 more Smart Citations

Pharmacist care in Federally Qualified Health Centers: A narrative review

Rodis

Irwin

Valentino

et al. 2022

J Am Coll Clin Pharm

Self Cite

View full text Add to dashboard Cite

Federally Qualified Health Centers (FQHCs) are critical to providing care to underserved populations in the United States. Their focus on interprofessional care has also made FQHCs ideal locations to integrate pharmacists into care teams and advance pharmacy practice. However, despite long-standing involvement by pharmacists, there have been limited attempts to synthesize this literature. We conducted a comprehensive search for published literature on the roles of pharmacists in FQHCs and narrowed our search to 54 manuscripts and abstracts for inclusion in this narrative review. We found that pharmacists in FQHCs are providing care that is interprofessional, multifaceted, and evolving rapidly in response to environmental changes.Pharmacists are routinely involved in the traditional management of chronic disease, such as diabetes, hypertension, behavioral health, and respiratory conditions. In addition, pharmacists have forged roles in preventive care, infectious disease, and pain management. Models include appointment-based approaches; however, there was also heterogeneity in approaches consistent with the dynamic nature of the healthcare system in the United States with engagement in population health, transitions of care, and telehealth, as a few examples. Collaborative practice agreements were used to deliver care in some cases, although this was not commonplace, and reimbursement by third party payers was rarely addressed. Relationships with community pharmacies, often driven by the 340B Drug Pricing Program, were also noted.Recommendations for future research in this area include increasing the rigor of future research by standardizing pharmacy interventions and including comparator groups, a greater focus on financial sustainability, and further exploration of how state laws surrounding pharmacist provider status and scope of practice impact pharmacy service development.

show abstract

Section: Limitationsmentioning

confidence: 97%